KIT and myocardial infarction: It has been indicated that cardiovascular diseases such as MI may significantly impair the functional activity of endogenous stem cells and reduce the efficacy of implanted cells for therapeutic use [21–23], which partly explains why the transplanted c-kit+AT2R− subpopulation was not so efficient as expected on homing capacity and antiapoptosis in our study.